These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 10230180)

  • 41. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials.
    Ramtvedt BE; Røinås E; Aabech HS; Sundet KS
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):597-604. PubMed ID: 23659360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The challenges to demonstrating long-term effects of psychostimulant treatment for attention-deficit/hyperactivity disorder.
    Hazell P
    Curr Opin Psychiatry; 2011 Jul; 24(4):286-90. PubMed ID: 21519262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder.
    Castellanos FX; Elia J; Kruesi MJ; Marsh WL; Gulotta CS; Potter WZ; Ritchie GF; Hamburger SD; Rapoport JL
    Neuropsychopharmacology; 1996 Feb; 14(2):125-37. PubMed ID: 8822535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication and hyperactivity: a meta-analysis.
    Thurber S; Walker CE
    J Gen Psychol; 1983 Jan; 108(1st Half):79-86. PubMed ID: 6131929
    [No Abstract]   [Full Text] [Related]  

  • 45. Central nervous system stimulants for secondary attention deficit-hyperactivity disorder after paediatric traumatic brain injury: a rationale and protocol for single patient (n-of-1) multiple cross-over trials.
    Senior HE; McKinlay L; Nikles J; Schluter PJ; Carmont SA; Waugh MC; Epps A; Lloyd O; Mitchell GK
    BMC Pediatr; 2013 May; 13():89. PubMed ID: 23710976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; McNairn N; Clavarino A
    Eur J Clin Pharmacol; 2007 Nov; 63(11):985-9. PubMed ID: 17701403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methylphenidate vs dexamphetamine: a clinical audit.
    Green C
    J Paediatr Child Health; 1996 Oct; 32(5):470. PubMed ID: 8933415
    [No Abstract]   [Full Text] [Related]  

  • 48. Diagnosing and treating ADHD in adults.
    Scrandis DA
    Nurse Pract; 2018 Jan; 43(1):8-10. PubMed ID: 29240618
    [No Abstract]   [Full Text] [Related]  

  • 49. Medium-term outcomes are comparable with short-term outcomes in children with attention deficit hyperactivity disorder treated with stimulant medication.
    Efron D; Jarman FC; Barker MJ
    J Paediatr Child Health; 2000 Oct; 36(5):457-61. PubMed ID: 11036801
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential effects of methylphenidate on problem solving in adults with ADHD.
    Tucha L; Tucha O; Sontag TA; Stasik D; Laufkötter R; Lange KW
    J Atten Disord; 2011 Feb; 15(2):161-73. PubMed ID: 20484710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.
    New South Wales Department of Health
    N S W Public Health Bull; 2004; 15 Suppl 3():1-55. PubMed ID: 15448720
    [No Abstract]   [Full Text] [Related]  

  • 52. An update on attention deficit disorder.
    Harv Ment Health Lett; 2004 May; 20(11):4-7. PubMed ID: 15153391
    [No Abstract]   [Full Text] [Related]  

  • 53. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.
    Samuels JA; Franco K; Wan F; Sorof JM
    Pediatr Nephrol; 2006 Jan; 21(1):92-5. PubMed ID: 16254730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial.
    Ramtvedt BE; Sundet K
    Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adults with ADHD: ignored and under-treated.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):73. PubMed ID: 21752832
    [No Abstract]   [Full Text] [Related]  

  • 56. Thyroid function and attention-deficit hyperactivity disorder.
    Elia J; Gulotta C; Rose SR; Marin G; Rapoport JL
    J Am Acad Child Adolesc Psychiatry; 1994 Feb; 33(2):169-72. PubMed ID: 8150787
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of long-term stimulants on driving in adults with ADHD.
    Jerome L; Segal A
    J Nerv Ment Dis; 2001 Jan; 189(1):63-4. PubMed ID: 11206669
    [No Abstract]   [Full Text] [Related]  

  • 58. Stimulant drugs for severe hyperactivity in childhood.
    Drug Ther Bull; 2001 Jul; 39(7):52-4. PubMed ID: 11471516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulant treatment of bulimia nervosa with and without attention-deficit disorder: three case reports.
    Drimmer EJ
    Nutrition; 2003 Jan; 19(1):76-7. PubMed ID: 12507648
    [No Abstract]   [Full Text] [Related]  

  • 60. Child and parent perceptions of stimulant medication treatment in attention deficit hyperactivity disorder.
    Efron D; Jarman FC; Barker MJ
    J Paediatr Child Health; 1998 Jun; 34(3):288-92. PubMed ID: 9633980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.